Tell a Friend | SmartBrief

Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.

Referral Count:

Story being shared

Abbott's Humira gets FDA approval for ulcerative colitis

The FDA approved Abbott Laboratories' Humira, or adalimumab, to treat moderate to severe ulcerative colitis. The drug is already approved for indications including rheumatoid arthritis and Crohn's disease.

Or we can send an email on your behalf

Your name(s)

Your email

Your friend's email

Message

Agree to Terms & Conditions

You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .